Rituximab in hematopoietic cell transplantation. - Wikidata - awgldk - TriplyDB

Rituximab in hematopoietic cell transplantation.

Rituximab in hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q37737311

about

Cutaneous graft-versus-host disease: rationales and treatment options.Therapeutic benefits targeting B-cells in chronic graft-versus-host disease.

P2860

Q37853600-674D8FFD-B4C1-4987-BA43-6E418651215E Q38392246-A339C364-297E-4F3B-8E71-A79AB828F4CA

P2860

Rituximab in hematopoietic cell transplantation.

http://www.wikidata.org/entity/Q37737311

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rituximab in hematopoietic cell transplantation.

@en

Rituximab in hematopoietic cell transplantation.

@nl

type

label

Rituximab in hematopoietic cell transplantation.

@en

Rituximab in hematopoietic cell transplantation.

@nl

prefLabel

Rituximab in hematopoietic cell transplantation.

@en

Rituximab in hematopoietic cell transplantation.

@nl

P1433

Q37737311-4BA0670A-78D9-468D-816F-2441B7475A2E

P1476

Q37737311-4C3F69C3-38A1-4DE4-AA65-10DEB830FA17

P2093

Q37737311-7C0D6342-47D0-4AA5-B271-D767A8BB88ED

Q37737311-8D934F1B-78BA-44E7-A16F-B7CAB4262916

P2860

Q37737311-0362976C-799A-4143-B057-07F8884B6516

Q37737311-0BFE36CB-09BB-4462-9E84-3AB11517CFC5

Q37737311-10037508-65E8-4F78-9CDB-D47C7B1F354C

Q37737311-181B28C4-7AE7-45CD-BB5C-17D94775E3EA

Q37737311-1F8C5DF9-6910-4D27-9FA5-C761E303C5CE

Q37737311-23E7A2A9-A068-41E0-BB74-49FC37852F44

Q37737311-272802A6-8885-457F-87AE-AC068C140EA0

Q37737311-2A72E6BE-385B-40E2-8FFA-A05690910FA6

Q37737311-32722487-BD71-4A9E-A1B9-4471FE303220

Q37737311-33E8AB2B-36F5-423D-A107-BC8BA481E8F0

P304

Q37737311-B422642D-BC0B-48BE-9BAF-C5903D4BA1AD

P31

Q37737311-B3FE2528-335D-4761-869F-26162F340799

P356

Q37737311-C67C8A0E-B34A-4D70-905B-96A695451F1B

P407

Q37737311-0AF5FE7A-5469-47D0-BE3A-B5A2CBA09794

P433

Q37737311-5EB6771F-C9C8-4012-A71E-4CA85D745199

P478

Q37737311-46DB2F47-D241-42CB-8BCC-0558E3ED74CE

P577

Q37737311-910DDC86-408F-4575-94AC-AC0B5979E1F6

P698

Q37737311-AA3D8F97-AF20-4D7B-A675-64D7E0BD3580

P356

14712598.2010.485982

P1433

Expert Opinion on Biological Therapy

P1476

Rituximab in hematopoietic cell transplantation.

@en

P2093

David B Miklos

http://www.w3.org/2001/XMLSchema#string

Sally Arai

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

B cells and transplantation: an educational resource.

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

P304

971-982

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2010.485982

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20420511

http://www.w3.org/2001/XMLSchema#string